Sponsor

Centre Leon Berard

Clinical research sponsor

Published trials49
Recruiting shown6
Roles2
SourceClinicalTrials.gov

Clinical trials

49 shown
Preoperative Magnetic Tracking in Breast Surgery in France: French Medical-economic Study.NCT06906601 · lead sponsor · 2025-04-15
RECRUITING
Evolution of Clinical and Motivational Constructs During the Physical Activity Program KHEOPS, Already Offered to Patients at the Centre Léon BérardNCT07515326 · lead sponsor · 2024-12-18
RECRUITING
FIRST-NEC (GFPC 01-2022) - Combination of Durvalumab With Etoposide and PlatinumNCT06393816 · lead sponsor · 2024-06-13
RECRUITING
Prospective Study of Immune Alterations in Operable Breast and Ovarian CarcinomaNCT04562623 · lead sponsor · 2021-07-01
RECRUITING
LIquid BIopsies in Patients Presenting Non-small Cell Lung CancerNCT02511288 · lead sponsor · 2015-07-01
RECRUITING
ERICA-02 Study : Impact of Physical Exercise on the Tumor Immune Microenvironment in Patients Treated With Neoadjuvant Chemoimmunotherapy for Non-small Cell Lung CancerNCT07786909 · lead sponsor · 2026-07-30
NOT_YET_RECRUITING
Enumeration and Functional Analysis of Circulating Tumor Cells for Homologous Recombination: a Prospective Single-center Study on Advanced/Metastatic Solid TumorsNCT07555600 · lead sponsor · 2026-05-01
NOT_YET_RECRUITING
Impact of a Hypnotic Recording on Artifacts in 4D CT in the Context of Stereotactic Body Radiation Therapy for Lung CancerNCT07334990 · lead sponsor · 2025-12-30
NOT_YET_RECRUITING
Lung Ultrasound Score After ENT Cancer SurgeryNCT05482841 · lead sponsor · 2022-12-01
UNKNOWN
Impact of Patient's Therapeutic Education in APA and Dietetic on Radiotherapy Reproducibility Sessions for Prostate CancerNCT04832113 · lead sponsor · 2021-06-21
UNKNOWN
MACSSI (MAstectomie Cellules Souches Surveillance Immunitaire)NCT03870802 · lead sponsor · 2021-02-22
UNKNOWN
Feasibility of an Acute Physical Exercise Before Treatment Infusion for Metastatic Lung Cancer PatientsNCT04676009 · lead sponsor · 2021-01-21
COMPLETED
A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors.NCT04671693 · lead sponsor · 2020-12-24
ACTIVE_NOT_RECRUITING
Evaluation of a ddPCR Technology for the SARS-CoV-2 Detection in Symptomatic Patients With Suspicion of COVID-19NCT04510454 · lead sponsor · 2020-11-02
COMPLETED
A Physical Activity Program to Improve Quality of Life and Reduce Fatigue in Metastatic Breast CancerNCT04354233 · lead sponsor · 2020-06-24
COMPLETED
Cicaderma Efficacy vs Standard Care of Sites in Preventing Radiodermatitis in Non-metastatic Breast Cancer PatientsNCT04300829 · lead sponsor · 2020-06-06
UNKNOWN
Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 InfectionNCT04333914 · lead sponsor · 2020-04-15
COMPLETED
Prospective Analysis of Morbi-mortality of Patients With Cancers in Active Phase of Treatment Suspected or Diagnosed of a SARS-CoV-2 InfectionNCT04363632 · lead sponsor · 2020-04-02
COMPLETED
Satisfaction & Efficacy of Compression Using Surgical Gloves in Chemo-induced Peripheral NeuropathiesNCT03872908 · lead sponsor · 2019-09-29
UNKNOWN
Evaluate the Clinical Benefit of a Post-operative Treatment Associating Radiotherapy + Nivolumab + Ipilimumab Versus Radiotherapy + Capecitabine for Triple Negative Breast Cancer Patients With Residual DiseaseNCT03818685 · lead sponsor · 2019-07-02
UNKNOWN
Evaluation of the Feasibility and Clinical Relevance of Liquid Biopsy in Patients With Suspicious Metastatic Lung CancerNCT03721120 · lead sponsor · 2019-04-10
COMPLETED
Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2+ Breast Cancer Breast CancerNCT03571633 · lead sponsor · 2018-08-06
ACTIVE_NOT_RECRUITING
Efficacy of Exercise Using Connected Activity Trackers and Therapeutic Education in Localized Breast CancerNCT03529383 · lead sponsor · 2018-05-18
COMPLETED
Satisfaction and Quality of Life Comparison Between Patients Using Cicaplast Baume B5 Versus Dexeryl for the Management of Cutaneous Toxicities Induced by Epidermal Growth Factor Receptor Inhibitors (iEGFR)NCT03421912 · lead sponsor · 2018-02-16
COMPLETED
Iterative PICC Placement Versus Long Term DeviceNCT02784730 · lead sponsor · 2018-01-10
WITHDRAWN
Evaluation of Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated With Metronomic CyclophosphamideNCT03139851 · lead sponsor · 2017-06-27
COMPLETED
Advanced Breast Cancer and Lifestyle Exercise StudyNCT03148886 · lead sponsor · 2016-10-01
COMPLETED
Evaluation of Percutaneous Treatment by Cryoablation of Unifocal Invasive Breast Carcinoma in Menopausal Women With Indication of LumpectomyNCT02576106 · lead sponsor · 2016-02-01
COMPLETED
Study of the Impact of Everolimus Treatment on Lymphocytes NK (Natural Killer) Development and Functions for Patients With a Metastatic Breast Cancer (HR+ / HER2/Neu Negative)NCT02536625 · lead sponsor · 2015-10-01
COMPLETED
Study of the Efficacy of SBRT on Unresectable Peripheral Primary TumorNCT02400424 · lead sponsor · 2015-02-01
TERMINATED
Study of SBRT Efficacy on Intra and Extra -Cranial Tumors or Metastasis in Pediatrics Population (SBRT Pediatrics)NCT02013297 · lead sponsor · 2013-12-03
COMPLETED
Phase 2 Study Evaluating Mid-position Strategy in Radiotherapy Treatment for Patients With a Locally Advanced Non-small Cell Lung CarcinomaNCT01635270 · lead sponsor · 2012-09-12
COMPLETED
Evaluation of the Predictive and Prognostic Value of Germ-line Polymorphisms in Patients With Metastatic Breast CancerNCT01460186 · lead sponsor · 2011-12-01
COMPLETED
Study of the Response to a Neoadjuvant Chemotherapy Based on the Antitumor Immune Response in Localized Breast CancerNCT01440413 · lead sponsor · 2011-12-01
UNKNOWN
Impact of Nutritional Intervention in Women With Breast Cancer Under Adjuvant ChemotherapyNCT01331772 · lead sponsor · 2011-07-01
COMPLETED
Study Evaluating Impact of IL-7 on CD4 Lymphopenia, Risks of Severe Haematological Toxicity and Tumor Progression in Metastatic Breast Cancer PatientsNCT01368107 · lead sponsor · 2011-06-01
COMPLETED
Comparative Evaluation of Osteopathy Treatment Efficacy in Pain Support After Breast Surgery in OncologyNCT01403168 · lead sponsor · 2011-04-01
TERMINATED
Prognostic Value of Divpenia and CD4 Count in Relapsed Breast or Lung Cancer PatientsNCT01306188 · lead sponsor · 2010-07-01
COMPLETED
Evaluation of Homeopathic Treatment for Hot Flashes in Non Metastatic Breast CancerNCT01246427 · lead sponsor · 2010-01-01
COMPLETED
Stereotactic Body Radio Therapy (SBRT) for Early-stage Non Small Cell Lung Cancer (NSCLC)NCT00870116 · lead sponsor · 2009-04-01
UNKNOWN
Study of Impact of Routine "Clinical Cancer Department/Supportive Care Department" Consultation on the Prescription of an Additional Line of ChemotherapyNCT00905281 · lead sponsor · 2008-11-01
COMPLETED
Axillary Sentinel Lymph Node Detection in Breast Cancers > 2 cmNCT00636467 · lead sponsor · 2008-03-01
COMPLETED
Prevention of Radiation Pneumonitis After Three-dimensional Conformal Radiation Therapy (3D-CRT) in Patients With Non-small-cell Lung CancerNCT00349102 · lead sponsor · 2006-07-01
COMPLETED
Placebo-controlled Evaluation of Cocculine® Efficacy in the Management of Nausea After Chemotherapy in Breast Cancer.NCT00409071 · lead sponsor · 2005-09-01
COMPLETED
Carboplatin-Etoposide Combination in Hormone-Resistant Prostate CancersNCT00973882 · lead sponsor · 2005-04-01
COMPLETED
Analyzing and Solving Exceptional Long-term Survivors in Solid Tumors With Poor PrognosisNCT06160596 · collaborator · 2023-11-01
RECRUITING
Virtual RealiTy and mUsic in the Oncology SEtting - Phase 1NCT06305117 · collaborator · 2024-11-20
COMPLETED
A Study to Assess the Efficacy and Safety of ABTL0812NCT03366480 · collaborator · 2016-12-01
COMPLETED
Intrathecal Trastuzumab Administration in Metastatic Breast Cancer Patients Developing Carcinomatous MeningitisNCT01373710 · collaborator · 2011-05-19
COMPLETED

Sponsor roles

lead sponsor45
collaborator4

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.